Elos Medtech’s Rights Offering

Roschier advised TA Associates on the offering. Elos Medtech completed a SEK 4.3 billion rights offering. The rights issue was fully underwritten by the principal shareholder...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Vitruvian’s Acquisition of Aspia

Kirkland & Ellis is advising Vitruvian Partners in the transaction, while Roschier and MCF are representing IK Partners. Vitruvian Partners announced it has agreed to acquire Aspia...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here